GSK in talks to buy cancer biotech Nuvalent for more than $9bn
RSS SUMMARY · AGGREGATED FROM FT
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
Continue Reading
The full story continues on Financial Times.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
FT
Business
Apollo and Blackstone raise $35bn in chip financing deal for Anthropic
FT·4h ago·3 min read
Business
OpenAI files to go public in blockbuster listing
FT·6h ago·3 min read
Business
Apple unveils long-awaited AI Siri after years of delays
FT·7h ago·3 min read
Business
Trump’s $100,000 H-1B visa fee blocked by judge
FT·8h ago·3 min read
Related
On this beat
Business
Intel gains on report that Google will use it to make chips
FP·11h ago·3 min read
Business
Bitcoin’s US$235 billion crash masks a bigger shift across crypto
FP·11h ago·3 min read
Business
More Americans hold multiple jobs with Gen Z leading the surge
FP·12h ago·3 min read
Business
U.S. dollar is best bet in new global regime of high rates, BMO says
FP·11h ago·3 min read